On the basis of the findings, a diagnosis of leukemic phase ALK-negative (triple negative) ALCL Stage IV B X age-adjusted International Prognostic Scoring index (aa-IPI: 4) was made. The gene discussed is ALK; the disease is anaplastic large cell lymphoma.